Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Systematic analysis of dopamine receptor genes (DRD1-DRD5) in antipsychotic-induced weight gain.

Müller DJ, Zai CC, Sicard M, Remington E, Souza RP, Tiwari AK, Hwang R, Likhodi O, Shaikh S, Freeman N, Arenovich T, Heinz A, Meltzer HY, Lieberman JA, Kennedy JL.

Pharmacogenomics J. 2012 Apr;12(2):156-64. doi: 10.1038/tpj.2010.65. Epub 2010 Aug 17.

PMID:
20714340
2.

Association study of polymorphisms in insulin induced gene 2 (INSIG2) with antipsychotic-induced weight gain in European and African-American schizophrenia patients.

Tiwari AK, Zai CC, Meltzer HY, Lieberman JA, Müller DJ, Kennedy JL.

Hum Psychopharmacol. 2010 Apr;25(3):253-9. doi: 10.1002/hup.1111.

PMID:
20373477
3.

Association study between antipsychotics- induced restless legs syndrome and polymorphisms of dopamine D1, D2, D3, and D4 receptor genes in schizophrenia.

Kang SG, Lee HJ, Choi JE, Park YM, Park JH, Han C, Kim YK, Kim SH, Lee MS, Joe SH, Jung IK, Kim L.

Neuropsychobiology. 2008;57(1-2):49-54. doi: 10.1159/000129667. Epub 2008 May 2.

PMID:
18451638
4.

No association of antipsychotic agent-induced weight gain with a DA receptor gene polymorphism and therapeutic response.

Zhang ZJ, Yao ZJ, Zhang XB, Chen JF, Sun J, Yao H, Hou G, Zhang XB.

Acta Pharmacol Sin. 2003 Mar;24(3):235-40.

5.

Association study between variants of AMP-activated protein kinase catalytic and regulatory subunit genes with antipsychotic-induced weight gain.

Souza RP, Tiwari AK, Chowdhury NI, Ceddia RB, Lieberman JA, Meltzer HY, Kennedy JL, Müller DJ.

J Psychiatr Res. 2012 Apr;46(4):462-8. doi: 10.1016/j.jpsychires.2012.01.010. Epub 2012 Feb 2.

PMID:
22305490
6.

The SNAP-25 gene may be associated with clinical response and weight gain in antipsychotic treatment of schizophrenia.

Müller DJ, Klempan TA, De Luca V, Sicard T, Volavka J, Czobor P, Sheitman BB, Lindenmayer JP, Citrome L, McEvoy JP, Lieberman JA, Honer WG, Kennedy JL.

Neurosci Lett. 2005 May 6;379(2):81-9. Epub 2005 Jan 26.

PMID:
15823421
7.

DRD4 48 bp VNTR but not 5-HT 2C Cys23Ser receptor polymorphism is related to antipsychotic-induced weight gain.

Popp J, Leucht S, Heres S, Steimer W.

Pharmacogenomics J. 2009 Feb;9(1):71-7. doi: 10.1038/tpj.2008.5. Epub 2008 Mar 11.

PMID:
18332898
8.

Polymorphisms in dopamine receptor DRD1 and DRD2 genes and psychopathological and extrapyramidal symptoms in patients on long-term antipsychotic treatment.

Dolzan V, Plesnicar BK, Serretti A, Mandelli L, Zalar B, Koprivsek J, Breskvar K.

Am J Med Genet B Neuropsychiatr Genet. 2007 Sep 5;144B(6):809-15.

PMID:
17455212
9.

Pharmacogenomic associations with weight gain in olanzapine treatment of patients without schizophrenia.

Houston JP, Kohler J, Bishop JR, Ellingrod VL, Ostbye KM, Zhao F, Conley RR, Poole Hoffmann V, Fijal BA.

J Clin Psychiatry. 2012 Aug;73(8):1077-86. doi: 10.4088/JCP.11m06916.

PMID:
22967772
10.

The role of brain-derived neurotrophic factor (BDNF) gene variants in antipsychotic response and antipsychotic-induced weight gain.

Zai GC, Zai CC, Chowdhury NI, Tiwari AK, Souza RP, Lieberman JA, Meltzer HY, Potkin SG, Müller DJ, Kennedy JL.

Prog Neuropsychopharmacol Biol Psychiatry. 2012 Oct 1;39(1):96-101. doi: 10.1016/j.pnpbp.2012.05.014. Epub 2012 May 27.

PMID:
22642961
11.

Antipsychotic-induced weight gain and therapeutic response: a differential association.

Czobor P, Volavka J, Sheitman B, Lindenmayer JP, Citrome L, McEvoy J, Cooper TB, Chakos M, Lieberman JA.

J Clin Psychopharmacol. 2002 Jun;22(3):244-51.

PMID:
12006893
12.

Association study of polymorphisms in cholecystokinin gene and its receptors with antipsychotic induced weight gain in schizophrenia patients.

Tiwari AK, Rodgers JB, Sicard M, Zai CC, Likhodi O, Freeman N, Meltzer HY, Lieberman JA, Kennedy JL, Müller DJ.

Prog Neuropsychopharmacol Biol Psychiatry. 2010 Dec 1;34(8):1484-90. doi: 10.1016/j.pnpbp.2010.08.009. Epub 2010 Aug 20.

PMID:
20732371
13.

[Association of antipsychotic agent-induced weight gain with a polymorphism of the promotor region of the 5-HT2C receptor gene].

Zhang Z, Zhang X, Yao Z, Chen J, Sun J, Yao H, Hou G, Zhang X, Reynolds GP.

Zhonghua Yi Xue Za Zhi. 2002 Aug 25;82(16):1097-101. Chinese.

PMID:
12425817
14.

Association between the insulin-induced gene 2 (INSIG2) and weight gain in a German sample of antipsychotic-treated schizophrenic patients: perturbation of SREBP-controlled lipogenesis in drug-related metabolic adverse effects?

Le Hellard S, Theisen FM, Haberhausen M, Raeder MB, Fernø J, Gebhardt S, Hinney A, Remschmidt H, Krieg JC, Mehler-Wex C, Nöthen MM, Hebebrand J, Steen VM.

Mol Psychiatry. 2009 Mar;14(3):308-17. doi: 10.1038/sj.mp.4002133. Epub 2008 Jan 15.

PMID:
18195716
15.

Variants of dopamine and serotonin candidate genes as predictors of response to risperidone treatment in first-episode schizophrenia.

Ikeda M, Yamanouchi Y, Kinoshita Y, Kitajima T, Yoshimura R, Hashimoto S, O'Donovan MC, Nakamura J, Ozaki N, Iwata N.

Pharmacogenomics. 2008 Oct;9(10):1437-43. doi: 10.2217/14622416.9.10.1437.

PMID:
18855532
16.

Pharmacogenetic Associations of Antipsychotic Drug-Related Weight Gain: A Systematic Review and Meta-analysis.

Zhang JP, Lencz T, Zhang RX, Nitta M, Maayan L, John M, Robinson DG, Fleischhacker WW, Kahn RS, Ophoff RA, Kane JM, Malhotra AK, Correll CU.

Schizophr Bull. 2016 Nov;42(6):1418-1437. doi: 10.1093/schbul/sbw058. Epub 2016 May 23. Review.

17.

Protein kinase cAMP-dependent regulatory type II beta (PRKAR2B) gene variants in antipsychotic-induced weight gain.

Gagliano SA, Tiwari AK, Freeman N, Lieberman JA, Meltzer HY, Kennedy JL, Knight J, Müller DJ.

Hum Psychopharmacol. 2014 Jul;29(4):330-5. doi: 10.1002/hup.2407. Epub 2014 Apr 16.

PMID:
24737441
18.

Association between common variants near the melanocortin 4 receptor gene and severe antipsychotic drug-induced weight gain.

Malhotra AK, Correll CU, Chowdhury NI, Müller DJ, Gregersen PK, Lee AT, Tiwari AK, Kane JM, Fleischhacker WW, Kahn RS, Ophoff RA, Meltzer HY, Lencz T, Kennedy JL.

Arch Gen Psychiatry. 2012 Sep;69(9):904-12.

19.

Reversal of antipsychotic-associated weight gain.

O'Keefe CD, Noordsy DL, Liss TB, Weiss H.

J Clin Psychiatry. 2003 Aug;64(8):907-12.

PMID:
12927005
20.

Association study of tardive dyskinesia and five DRD4 polymorphisms in schizophrenia patients.

Zai CC, Tiwari AK, Basile V, De Luca V, Müller DJ, King N, Voineskos AN, Remington G, Meltzer HY, Lieberman JA, Potkin SG, Kennedy JL.

Pharmacogenomics J. 2009 Jun;9(3):168-74. doi: 10.1038/tpj.2009.2. Epub 2009 Feb 24.

PMID:
19238168

Supplemental Content

Support Center